CVBF shorts retreat as options flip bullish
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
CVB Financial Corp. ends April with a strikingly different short profile than it had three weeks ago — and options traders have swung from extreme defensiveness to the most bullish positioning of the past year, all while the stock quietly adds 8% over the month.
Short sellers have been aggressively covering. SI hit 11% of free float on April 20 — the highest level in the 30-day window — and has since fallen to 6.5%, a drop of more than 40% on the week. The FINRA fortnightly print, which captures activity through April 15, still shows 10.4 million shares short with days-to-cover near 8 days, confirming the elevated base that shorts have been unwinding from. Availability in the lending market has loosened considerably as a result: utilization (the share of available stock already lent out) has fallen from 19.8% — its 52-week peak, hit on April 1 — to just 6.8%, suggesting the borrow market is now comfortably supplied. Cost to borrow followed a similar arc, spiking to 0.90% in mid-week before pulling back to 0.61% by Tuesday's close.
Options tell a different story entirely. The put/call ratio collapsed to 0.10 on April 28 — the lowest reading of the past 52 weeks, against a 20-day average above 5.0, and nearly three standard deviations below that mean. For most of April, options flow had been running heavily put-dominated; Tuesday's session saw a dramatic rotation into calls. This is the year's most bullish single-day options reading for CVBF, and it arrived on the same day shorts covered hard — a convergence worth noting.
On the Street, the tone is cautiously constructive. Piper Sandler raised its target to $27 on April 27, maintaining an Overweight rating — the most recent analyst action and a modest step-up from the prior $26 target. The mean price target across covering analysts runs to $24.00, implying around 17% upside from the current $20.49 close. Bulls point to improving NIM, higher EPS estimates for 2025 and 2026, and disciplined cost management. Bears flag a 9% quarter-on-quarter decline in core noninterest income and ongoing pressure on loan and deposit pricing. The P/E multiple runs at 11.8x — up roughly 0.6x over the past 30 days — while P/B has expanded to 1.10x. The 90-day EPS momentum factor score of 75 puts the company in the upper quartile on earnings trajectory.
The ownership structure is stable and index-heavy. BlackRock holds 14.1% of shares, Vanguard 10.8%, and Dimensional 5.4% — all adding modestly at the March quarter-end. The most notable move belongs to FMR (Fidelity), which added 885,000 shares through February. Insider activity through late March was routine: the March 16 cycle saw equity award grants to the CEO, CFO, and COO alongside tax-related sell transactions, netting to a positive 64,000 shares over the 90-day window, with zero large discretionary open-market sells.
The next earnings event is scheduled for May 20. After last quarter's Q4 print, the stock fell 4.3% on the day and an additional 0.6% over the following week. The short score has dropped sharply this week — from 62.9 on April 20 to 46.4 on April 28 — tracking the covering activity in near real-time. What the May print will determine is whether the short rebuilding episode of early April was a structural re-rating of credit concerns or simply a macro-driven momentum trade that has now fully unwound.
Stocks in this article
See the live data behind this article on ORTEX.
Open CVBF on ORTEX →How this article was generated
- Generated
- 30 Apr 2026, 00:20
- Data as of
- 30 Apr 2026, 00:19
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signals
- Validation notes
- soft: missing section mentions: short interest (informational only)
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.